238 related articles for article (PubMed ID: 31428922)
1. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.
He YE; Qiu HX; Wu RZ; Rong X; Xu HT; Xiang RL; Chu MP
J Cardiovasc Transl Res; 2020 Apr; 13(2):204-214. PubMed ID: 31428922
[TBL] [Abstract][Full Text] [Related]
2. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
Nakashima Y; Sakai Y; Mizuno Y; Furuno K; Hirono K; Takatsuki S; Suzuki H; Onouchi Y; Kobayashi T; Tanabe K; Hamase K; Miyamoto T; Aoyagi R; Arita M; Yamamura K; Tanaka T; Nishio H; Takada H; Ohga S; Hara T
Cardiovasc Res; 2021 Jan; 117(1):96-108. PubMed ID: 31782770
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
4. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
5. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia.
English FA; McCarthy FP; McSweeney CL; Quon AL; Morton JS; Sawamura T; Davidge ST; Kenny LC
Am J Hypertens; 2013 Feb; 26(2):279-86. PubMed ID: 23382414
[TBL] [Abstract][Full Text] [Related]
8. Plasma H2S predicts coronary artery lesions in children with Kawasaki disease.
Sun Y; Yuan Y; Yan H; Wan H; Li X; Chen S; Li H; Tang C; Du J; Liu G; Jin H
Pediatr Int; 2015 Oct; 57(5):840-4. PubMed ID: 25808254
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
Chen YL; Wang JL; Li WQ
Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
[TBL] [Abstract][Full Text] [Related]
10. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A; Pal P; Basu S
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[TBL] [Abstract][Full Text] [Related]
11. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
[TBL] [Abstract][Full Text] [Related]
12. Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.
Song RX; Zou QM; Li XH; Xu NP; Zhang T; Fu J; Cui XD
Pediatr Res; 2016 Feb; 79(2):301-7. PubMed ID: 26536449
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
[TBL] [Abstract][Full Text] [Related]
14. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in children within 5 years after onset of Kawasaki disease.
Ishikawa T; Iwashima S
J Pediatr; 2013 Oct; 163(4):1117-21. PubMed ID: 23759425
[TBL] [Abstract][Full Text] [Related]
16. The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease.
Ishikawa T; Seki K
BMC Cardiovasc Disord; 2018 Feb; 18(1):30. PubMed ID: 29426283
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L
J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704
[TBL] [Abstract][Full Text] [Related]
18. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
Wang L; Yang Y; Cui Q; Cui Y; Li Q; Che X; Wang C; Quan P; Hu X
J Investig Med; 2021 Jan; 69(1):13-19. PubMed ID: 33004469
[TBL] [Abstract][Full Text] [Related]
20. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
